Sumanta Kumar Pal, M.D., FASCO
- Kidney Cancer
- Bladder Cancer
- Prostate Cancer
- Urologic Cancers
- Chair, Kidney and Bladder Cancer Disease Team
- Co-director, Kidney Cancer Program
- Professor, Department of Medical Oncology & Therapeutics Research
- Vice Chair of Academic Affairs, Department of Medical Oncology & Therapeutics Research
Dr. Pal entered college at the age of 13 and began medical school at University of California Los Angeles at the age of 17. After completing his residency training at UCLA, Dr. Pal completed a fellowship program in medical oncology at City of Hope's comprehensive cancer center where he has remained on faculty since 2009.
Over that span of time, he has published more than 500 PubMed cited articles that have been featured in prominent journals including Cancer Discovery, The Journal of Clinical Oncology, The Lancet, Cancer Cell and Nature Medicine.
Dr. Pal holds patents for new drugs currently under development in prostate cancer and also maintains one of the largest portfolios of clinical trials for kidney and bladder cancer research on the West Coast. He developed an integrated program that focuses heavily on collaborations with basic science researchers at the Beckman Research Institute of City of Hope and urologists in the Department of Surgery. Ultimately, Dr. Pal’s goal is to stimulate collaborative research across multiple departments in order to discover novel therapeutic approaches for currently incurable diseases. He has also worked to push the boundaries of personalized medicine in genitourinary cancers with several seminal publications in rare genitourinary cancers that describe unique therapeutic targets. He is the lead investigator on multiple trials, ranging from early phase 1 experiences to late stage phase 3 studies.
Location
Duarte Cancer Center
Duarte, CA 91010
Orange County Lennar Foundation Cancer Center
Irvine, CA 92618
Education & Experience
2009 - present, American Board of Internal Medicine, Medical Oncology
2006 - 2016, American Board of Internal Medicine
2003, M.D., David Geffen School of Medicine at UCLA, Los Angeles, CA
1998, Magna Cum Laude, B.Sc., California State University Los Angeles Early Entrance Program, College in lieu of high school (program initiated at age 13)
2006-2009, Fellowship in Hematology/Oncology, City of Hope/Harbor-UCLA Medical Center, Los Angeles, CA
2004-2006, Internal Medicine, UCLA Medical Center, Los Angeles, CA
2003-2004, Internal Medicine, UCLA Medical Center, Los Angeles, CA
2020-present, Professor, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA
2016-present, Disease Team Chair, Bladder & Kidney Cancer
2016-2020, Associate Clinical Professor, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA
2009-present, Co-director, Kidney Cancer Program, City of Hope, Duarte, CA
2009-2016, Assistant Clinical Professor, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA
Awards & Memberships
Awards
2021, Fellow of the American Society of Clinical Oncology (FASCO)
2021, City of Hope - 5 Star Rating Patient Satisfaction Award
2020, 40 Under 40 in Cancer
2020, Los Angeles Business Journal, Top Doctor
2020, City of Hope, Clinical Teaching Award
2018, City of Hope Mentor of the Year Award
Memberships
2018-present, Trials Consortium (SUO-CTC)
2017-2019, Cancer Communications Committee, Chair
2016-present, Leadership Development Program
2015-present, Social Media Working Group
2013-present, Genitourinary Cancers Committee
2012-2013, HER2-Positive Breast Cancer Committee
2010-present, National Comprehensive Cancer Network Bladder Cancer Committee
2015-present, Kidney Cancer Association Scientific Program Committee, Chair
2015-present, Society of Immunotherapy for Cancer Patient Meeting, Chair
2015-present, Society of Urologic Oncology Prostate Cancer Committee, Chair
2006-present, American Society of Clinical Oncology